✦ LIBER ✦
423 Phase 3 study of adjuvant radiotherapy vs wait and see after radical prostatectomy in pT3 prostate cancer (ARO 96-02 trial) – persisting PSA is a prognostic factor and correlates with worse 10-year survival
✍ Scribed by Wiegel, T.; Bartkowiak, D.; Bottke, D.; Hinke, A.; Stöckle, M.; Wirth, M.; Semjonow, A.; Miller, K.
- Book ID
- 122185799
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 111 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1569-9056
No coin nor oath required. For personal study only.